FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nicorette (nicotine polacrylex) from Haleon US Holdings LLC, marking an updated labeling under NDA 22360.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• NICORETTE (Nicotine polacrilex)

Snippet

SUPPL AP for NICORETTE (NICOTINE POLACRILEX)